Endocrine Disorders in Children with Prader-Willi Syndrome - Data from 142 Children of the French Database

被引:127
作者
Diene, G.
Mimoun, E.
Feigerlova, E.
Caula, S.
Molinas, C.
Grandjean, H. [2 ,3 ]
Tauber, M. [1 ]
机构
[1] Hop Enfants, Unit Endocrinol, Ctr Reference Syndrome Prader Willi, Div Endocrinol Genet Gynaecol & Bone Dis, FR-31059 Toulouse 9, France
[2] Univ Toulouse 3, Natl Inst Hlth & Med Res, INSERM, U558, F-31062 Toulouse, France
[3] Hosp Toulouse, Unit Clin Res, Toulouse, France
来源
HORMONE RESEARCH IN PAEDIATRICS | 2010年 / 74卷 / 02期
关键词
Prader-Willi syndrome; Endocrine disorders; children; Growth hormone deficiency; Obesity; Endocrine dysfunction; GROWTH-HORMONE TREATMENT; BODY-MASS INDEX; CARBOHYDRATE-METABOLISM; GH THERAPY; SCOLIOSIS; HYPOGONADISM; PREVALENCE; SECRETION; DIAGNOSIS; OBESITY;
D O I
10.1159/000313377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The first results from the French National Prader-Willi pediatric database in a cohort of 142 children aged 0.2-18.8 years are reported. This database gathers information about the endocrine dysfunctions traditionally described in Prader-Willi patients. Methods: Questionnaires were filled in by the patients' practitioners. The coordination team of the reference center performed the statistical analysis. Results: Median BMI Z-score was +1.3 for a median age of 7.1 years, and 40% of the population were overweight or obese (International Obesity Task Force 2000 criteria). Growth hormone deficiency was present in 80% of patients and 86.7% were treated, with a height gain of +1 SD and a BMI reduction of -0.8 Z-score achieved in the first year of treatment. Hypogonadism was present in 49% of patients, and hypothyroidism in 24.4%. Glucose intolerance was found in 4% of patients, but no diabetes mellitus was detected in the 74 patients explored. Conclusion: Our report gives an overview of endocrine dysfunctions recorded in a large registry database of French children and adolescents with Prader-Willi syndrome. The database, which now encompasses six southern regions of France, will be further extended to the whole country and to adult patients. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:121 / 128
页数:8
相关论文
共 45 条
[1]  
American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42
[2]  
Angulo M, 1996, J PEDIATR ENDOCR MET, V9, P393
[3]   Early diagnosis and multidisciplinary care reduce the hospitalization time and duration of tube feeding and prevent early obesity in PWS infants [J].
Bachere, N. ;
Diene, G. ;
Delagnes, V. ;
Molinas, C. ;
Moulin, P. ;
Tauber, M. .
HORMONE RESEARCH, 2008, 69 (01) :45-52
[4]   Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study [J].
Butler, JV ;
Whittington, JE ;
Holland, AJ ;
Boer, H ;
Clarke, D ;
Webb, T .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2002, 44 (04) :248-255
[5]   Thyroid function studies in Prader-Willi syndrome [J].
Butler, Merlin G. ;
Theodoro, Mariana ;
Skouse, Jennifer D. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (05) :488-492
[6]   Benefits of long-term GH therapy in Prader-Willi syndrome: A 4-year study [J].
Carrel, AL ;
Myers, SE ;
Whitman, BY ;
Allen, DB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1581-1585
[7]  
Cole T J, 2004, BMC Pediatr, V4, P6
[8]   Establishing a standard definition for child overweight and obesity worldwide: international survey [J].
Cole, TJ ;
Bellizzi, MC ;
Flegal, KM ;
Dietz, WH .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7244) :1240-1243
[9]   GROWTH-HORMONE SECRETION IN PRADER-WILLI SYNDROME [J].
COSTEFF, H ;
HOLM, VA ;
RUVALCABA, R ;
SHAVER, J .
ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (11) :1059-1062
[10]   Growth hormone treatment and adverse events in Prader-Willi syndrome: Data from KIGS (the Pfizer International Growth Database) [J].
Craig, Maria E. ;
Cowell, Christopher T. ;
Larsson, Pontus ;
Zipf, William B. ;
Reiter, Edward O. ;
Wikland, Kerstin Albertsson ;
Ranke, Michael B. ;
Price, David A. .
CLINICAL ENDOCRINOLOGY, 2006, 65 (02) :178-185